51 related articles for article (PubMed ID: 31730901)
1. TRAF7 enhances ubiquitin-degradation of KLF4 to promote hepatocellular carcinoma progression.
He H; Wu Z; Li S; Chen K; Wang D; Zou H; Chen H; Li Y; Liu Z; Qu C
Cancer Lett; 2020 Jan; 469():380-389. PubMed ID: 31730901
[TBL] [Abstract][Full Text] [Related]
2. Dysregulated Krüppel-like factor 4 and vitamin D receptor signaling contribute to progression of hepatocellular carcinoma.
Li Q; Gao Y; Jia Z; Mishra L; Guo K; Li Z; Le X; Wei D; Huang S; Xie K
Gastroenterology; 2012 Sep; 143(3):799-810.e2. PubMed ID: 22677193
[TBL] [Abstract][Full Text] [Related]
3. Unveiling the role of the KLF4/Lnc18q22.2/ULBP3 axis in the tumorigenesis and immune escape of hepatocellular carcinoma under hypoxic condition.
Wei L; He P; Tan Z; Zhao L; Lin C; Wei Z
J Cell Mol Med; 2024 May; 28(10):e18411. PubMed ID: 38780505
[TBL] [Abstract][Full Text] [Related]
4. TRIM47-CDO1 axis dictates hepatocellular carcinoma progression by modulating ferroptotic cell death through the ubiquitin‒proteasome system.
Zhang J; Yimamu M; Cheng Z; Ji J; Wu L; Feng J; Xu X; Wu J; Guo C
Free Radic Biol Med; 2024 Jul; 219():31-48. PubMed ID: 38614226
[TBL] [Abstract][Full Text] [Related]
5. Hydrogen sulfide improves endothelial barrier function by modulating the ubiquitination degradation of KLF4 through TRAF7 S-sulfhydration in diabetic aorta.
Li Q; Kang J; Liu N; Huang J; Zhang X; Pang K; Zhang S; Wang M; Zhao Y; Dong S; Li H; Zhao D; Lu F; Zhang W
Free Radic Biol Med; 2024 Apr; 216():118-138. PubMed ID: 38479633
[TBL] [Abstract][Full Text] [Related]
6. Pleiotropic role of TRAF7 in skull-base meningiomas and congenital heart disease.
Mishra-Gorur K; Barak T; Kaulen LD; Henegariu O; Jin SC; Aguilera SM; Yalbir E; Goles G; Nishimura S; Miyagishima D; Djenoune L; Altinok S; Rai DK; Viviano S; Prendergast A; Zerillo C; Ozcan K; Baran B; Sencar L; Goc N; Yarman Y; Ercan-Sencicek AG; Bilguvar K; Lifton RP; Moliterno J; Louvi A; Yuan S; Deniz E; Brueckner M; Gunel M
Proc Natl Acad Sci U S A; 2023 Apr; 120(16):e2214997120. PubMed ID: 37043537
[TBL] [Abstract][Full Text] [Related]
7. Reply to Pisan et al.: Pathogenicity of inherited TRAF7 mutations in congenital heart disease.
Mishra-Gorur K; Barak T; Kaulen LD; Henegariu O; Jin SC; Aguilera SM; Yalbir E; Goles G; Nishimura S; Miyagishima D; Djenoune L; Altinok S; Rai DK; Viviano S; Prendergast A; Zerillo C; Ozcan K; Baran B; Sencar L; Goc N; Yarman Y; Ercan-Encicek AG; Bilguvar K; Lifton RP; Moliterno J; Louvi A; Yuan S; Deniz E; Brueckner M; Gunel M
Proc Natl Acad Sci U S A; 2024 Mar; 121(12):e2319578121. PubMed ID: 38466853
[No Abstract] [Full Text] [Related]
8. Phenotypic spectrum and transcriptomic profile associated with germline variants in TRAF7.
Castilla-Vallmanya L; Selmer KK; Dimartino C; Rabionet R; Blanco-Sánchez B; Yang S; Reijnders MRF; van Essen AJ; Oufadem M; Vigeland MD; Stadheim B; Houge G; Cox H; Kingston H; Clayton-Smith J; Innis JW; Iascone M; Cereda A; Gabbiadini S; Chung WK; Sanders V; Charrow J; Bryant E; Millichap J; Vitobello A; Thauvin C; Mau-Them FT; Faivre L; Lesca G; Labalme A; Rougeot C; Chatron N; Sanlaville D; Christensen KM; Kirby A; Lewandowski R; Gannaway R; Aly M; Lehman A; Clarke L; Graul-Neumann L; Zweier C; Lessel D; Lozic B; Aukrust I; Peretz R; Stratton R; Smol T; Dieux-Coëslier A; Meira J; Wohler E; Sobreira N; Beaver EM; Heeley J; Briere LC; High FA; Sweetser DA; Walker MA; Keegan CE; Jayakar P; Shinawi M; Kerstjens-Frederikse WS; Earl DL; Siu VM; Reesor E; Yao T; Hegele RA; Vaske OM; Rego S; ; Shapiro KA; Wong B; Gambello MJ; McDonald M; Karlowicz D; Colombo R; Serretti A; Pais L; O'Donnell-Luria A; Wray A; Sadedin S; Chong B; Tan TY; Christodoulou J; White SM; Slavotinek A; Barbouth D; Morel Swols D; Parisot M; Bole-Feysot C; Nitschké P; Pingault V; Munnich A; Cho MT; Cormier-Daire V; Balcells S; Lyonnet S; Grinberg D; Amiel J; Urreizti R; Gordon CT
Genet Med; 2020 Jul; 22(7):1215-1226. PubMed ID: 32376980
[TBL] [Abstract][Full Text] [Related]
9. The deubiquitinase USP10 regulates KLF4 stability and suppresses lung tumorigenesis.
Wang X; Xia S; Li H; Wang X; Li C; Chao Y; Zhang L; Han C
Cell Death Differ; 2020 Jun; 27(6):1747-1764. PubMed ID: 31748695
[TBL] [Abstract][Full Text] [Related]
10. USP10 Promotes Proliferation of Hepatocellular Carcinoma by Deubiquitinating and Stabilizing YAP/TAZ.
Zhu H; Yan F; Yuan T; Qian M; Zhou T; Dai X; Cao J; Ying M; Dong X; He Q; Yang B
Cancer Res; 2020 Jun; 80(11):2204-2216. PubMed ID: 32217697
[TBL] [Abstract][Full Text] [Related]
11. Advances in molecular classification and precision oncology in hepatocellular carcinoma.
Rebouissou S; Nault JC
J Hepatol; 2020 Feb; 72(2):215-229. PubMed ID: 31954487
[TBL] [Abstract][Full Text] [Related]
12. Tackling hepatocellular carcinoma with individual or combinatorial immunotherapy approaches.
Tagliamonte M; Mauriello A; Cavalluzzo B; Ragone C; Manolio C; Petrizzo A; Buonaguro L
Cancer Lett; 2020 Mar; 473():25-32. PubMed ID: 31875523
[TBL] [Abstract][Full Text] [Related]
13. Upregulation of SNX5 predicts poor prognosis and promotes hepatocellular carcinoma progression by modulating the EGFR-ERK1/2 signaling pathway.
Zhou Q; Huang T; Jiang Z; Ge C; Chen X; Zhang L; Zhao F; Zhu M; Chen T; Cui Y; Li H; Yao M; Li J; Tian H
Oncogene; 2020 Mar; 39(10):2140-2155. PubMed ID: 31819169
[TBL] [Abstract][Full Text] [Related]
14. SERPINE2 promotes esophageal squamous cell carcinoma metastasis by activating BMP4.
Zhang J; Luo A; Huang F; Gong T; Liu Z
Cancer Lett; 2020 Jan; 469():390-398. PubMed ID: 31730904
[TBL] [Abstract][Full Text] [Related]
15. STIM1 is a metabolic checkpoint regulating the invasion and metastasis of hepatocellular carcinoma.
Zhao H; Yan G; Zheng L; Zhou Y; Sheng H; Wu L; Zhang Q; Lei J; Zhang J; Xin R; Jiang L; Zhang X; Chen Y; Wang J; Xu Y; Li D; Li Y
Theranostics; 2020; 10(14):6483-6499. PubMed ID: 32483465
[No Abstract] [Full Text] [Related]
16. USP22 promotes hypoxia-induced hepatocellular carcinoma stemness by a HIF1α/USP22 positive feedback loop upon TP53 inactivation.
Ling S; Shan Q; Zhan Q; Ye Q; Liu P; Xu S; He X; Ma J; Xiang J; Jiang G; Wen X; Feng Z; Wu Y; Feng T; Xu L; Chen K; Zhang X; Wei R; Zhang C; Cen B; Xie H; Song P; Liu J; Zheng S; Xu X
Gut; 2020 Jul; 69(7):1322-1334. PubMed ID: 31776228
[TBL] [Abstract][Full Text] [Related]
17. KLF4-mediated upregulation of CD9 and CD81 suppresses hepatocellular carcinoma development via JNK signaling.
Li Y; Yu S; Li L; Chen J; Quan M; Li Q; Gao Y
Cell Death Dis; 2020 Apr; 11(4):299. PubMed ID: 32350244
[TBL] [Abstract][Full Text] [Related]
18. Circular RNA Sequencing Identifies CircASAP1 as a Key Regulator in Hepatocellular Carcinoma Metastasis.
Hu ZQ; Zhou SL; Li J; Zhou ZJ; Wang PC; Xin HY; Mao L; Luo CB; Yu SY; Huang XW; Cao Y; Fan J; Zhou J
Hepatology; 2020 Sep; 72(3):906-922. PubMed ID: 31838741
[TBL] [Abstract][Full Text] [Related]
19. CircRNA-5692 inhibits the progression of hepatocellular carcinoma by sponging miR-328-5p to enhance DAB2IP expression.
Liu Z; Yu Y; Huang Z; Kong Y; Hu X; Xiao W; Quan J; Fan X
Cell Death Dis; 2019 Nov; 10(12):900. PubMed ID: 31776329
[TBL] [Abstract][Full Text] [Related]
20. Loss-of-Function Mutations in TRAF7 and KLF4 Cooperatively Activate RAS-Like GTPase Signaling and Promote Meningioma Development.
Najm P; Zhao P; Steklov M; Sewduth RN; Baietti MF; Pandolfi S; Criem N; Lechat B; Maia TM; Van Haver D; Corthout N; Eyckerman S; Impens F; Sablina AA
Cancer Res; 2021 Aug; 81(16):4218-4229. PubMed ID: 34215617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
